Inflammatory conversion of quiescent osteoblasts by metastatic breast cancer cells through pERK1/2 aggravates cancer-induced bone destruction.

MLA

Back, Jungho, et al. “Inflammatory Conversion of Quiescent Osteoblasts by Metastatic Breast Cancer Cells through PERK1/2 Aggravates Cancer-Induced Bone Destruction.” Bone Research, vol. 9, no. 1, Sept. 2021, pp. 1–14. EBSCOhost, https://doi.org/10.1038/s41413-021-00158-w.

APA

Back, J., Nguyen, M. N., Li, L., Lee, S., Lee, I., Chen, F., Gillinov, L., Chung, Y.-H., Alder, K. D., Kwon, H.-K., Yu, K. E., Dussik, C. M., Hao, Z., Flores, M. J., Kim, Y., Ibe, I. K., Munger, A. M., Seo, S. W., & Lee, F. Y. (2021). Inflammatory conversion of quiescent osteoblasts by metastatic breast cancer cells through pERK1/2 aggravates cancer-induced bone destruction. Bone Research, 9(1), 1–14. https://doi.org/10.1038/s41413-021-00158-w

Chicago

Back, Jungho, Minh Nam Nguyen, Lu Li, Saelim Lee, Inkyu Lee, Fancheng Chen, Lauren Gillinov, et al. 2021. “Inflammatory Conversion of Quiescent Osteoblasts by Metastatic Breast Cancer Cells through PERK1/2 Aggravates Cancer-Induced Bone Destruction.” Bone Research 9 (1): 1–14. doi:10.1038/s41413-021-00158-w.